On the other hand, the molecular mutational status of main CRC oncogenes (KRAS, NRAS, BRAF, PIK3CA), associated with microsatellite instability (MSI) status, is now performed in clinical routine for the management of CRC. This evidence concerns the gene BRAF and colorectal carcinoma.